Colesevelam hydrochloride
NDC 67877-523, Colesevelam hydrochloride, powder, for suspension, from Ascend Laboratories, LLC.
- Product NDC
- 67877-523
- Status
- Listed
- Labeler
- Ascend Laboratories, LLC
- Dosage form
- POWDER, FOR SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA210316
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/67877-523 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- COLESEVELAM HYDROCHLORIDE3.75 g/1
Pharmacologic classes
Bile Acid Sequestrant [EPC]; Bile-acid Binding Activity [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 67877-523-30 | 67877052330 | 30 POWDER, FOR SUSPENSION in 1 PACKET (67877-523-30) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/dfce5bc5-58fc-4fe5-b5c0-7a8026ee2b96NADAC price for package 67877052330
GET /v1/drugs/nadac/67877052330
Use it
Look up 67877-523 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/67877-523 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 67877-523. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.